Article
The role of p53 mutations as a prognostic factor and therapeutic target in inflammatory breast cancer.
Future oncology (London, England) - 1 Apr 2006
Yang Charles H, Cristofanilli Massimo
Abstract excerpt
Inflammatory breast cancer is a rare but lethal form of locally advanced breast cancer. Despite improvements in survival with the advent of multidisciplinary treatment regimens, 5-year survival rates remain disappointing, at approximately 30%. Numerous molecular markers have been investigated for their potential as useful prognostic and predictive markers of treatment response that would impact on the management...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.